Sharp seeks greater foothold in Chinese market through ClinsChain partnership
Sharp hopes teaming up with clinical service provider ClinsChain will open the door to the Chinese market
Sharp, a provider of clinical supply chain services and pharmaceutical packaging, announced a strategic partnership with Shanghai-based ClinsChain this week, with the intention of expanding its reach and capabilities in the Chinese market.
Sharp will partner with ClinsChain, who specialise in providing clinical supply services for local and global clinical trials, to facilitate access to the Chinese market for Sharp’s pharma and biopharma clients. The collaboration will also help Chinese companies to increase their global presence.
Sharp says it will now be able to offer pharma clients local expertise for their clinical studies.
Speaking about the news, Robert O’Beirn, Managing Director at Sharp Clinical commented: ‘We are delighted to announce our partnership with ClinsChain, demonstrating our commitment to supporting our clients in the burgeoning Chinese market.
‘This partnership represents an alliance of two trusted and experienced clinical service providers which will ensure our clients benefit from the best of local knowledge and global reach for their clinical trials.’
ClinsChain founder Paul Cao added that the company has ‘invested significant time looking for a strong global partner’ and had been ‘very impressed with Sharp’s experience and broad expertise in the clinical trial packaging market.’
He continued: ‘Expanding ClinsChain’s reach to new markets and helping Chinese innovators reach new global markets is a vital part of our growth strategy for the future. This partnership with Sharp is an important contribution to delivering that strategy.’
Sharp also recently expanded its clinical service offering in Europe through the addition of labelling and secondary packaging services at its Heerenveen facility in the Netherlands.
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance